Trial search
Nation, Province(City)
Code of disease
Primary sponsor(s)
Secondary sponsor(s)
Funding source
Recruiting status
Register status
Measure
Ethical committee
Study type
Trial search
Public title
Scientific title
Subject ID
Registration Status
Registration number
Secondary ID
Applicant
Study leader
Year
Primary sponsor
Secondary sponsor
Source(s) of funding
Target disease
Target disease code
Study type
Study phase
Study design
Recruiting status
Execute time(From)
Execute time(END)
Sign the informed consent
Gender
Nation(Area)
Province
City
Unit (hospital)
Institution
Level of the institution
Intervention
Intervention code
Approved by ethic committee
Calculated Results after the Study
Completed puboptionc access
3
trials have been registered
| Historical versions | Registration number | Public title | Type | Registration time |
|---|---|---|---|---|
| Historical Versions | ChiCTR2500110144 |
Using large models and artificial intelligence methods to study the prognosis and treatment response of multiple myeloma
The First Affiliated Hospital of Zhejiang University School of Medicine |
Observational study | 2025/10/09 |
| Historical Versions | ChiCTR2400084921 |
A Phase III Randomized, controlled study of Equecabtagene Autoleucel Injection in Subjects with Lenalidomide-Refractory RRMM (Relapse/Refractory Multiple Myeloma)
Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences |
Interventional study | 2024/05/28 |
| Historical Versions | ChiCTR1900024228 |
BCMA chimeric antigen receptor gene modified autologous T cells (BCMA CAR-T) for the treatment of multiple myeloma
Drum Tower Hospital Affiliated to Nanjing University Medical School |
Observational study | 2019/07/01 |
Chinese Clinical Trial Registry, Primary Registry of WHO International Clinical Trials Registry Platform
Copyright(c) (2005 - 2023) Chictr.org.cn.All rights reserved. Chinese Clinical Trial Registry
Note: It is recommended to use the widescreen display resolution of Internet Explorer 8.0 or later